LONDON, Aug. 18, 2016 /PRNewswire/ -- About OTC Drugs
OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores.
Technavio's analysts forecast the global over-the-counter (OTC) drug market to grow at a CAGR of 6.19% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global over-the-counter (OTC) drug market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of OTC drugs used to treat disorders, including gastrointestinal disorders, pain, and dermatological and respiratory disorders.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Technavio's report, Global Over-The-Counter (OTC) Drug Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Bayer HealthCare
- GlaxoSmithKline (GSK)
- Johnson & Johnson
- Pfizer
- Sanofi
Other prominent vendors
- Abbott
- Achelios Therapeutics
- American Health
- Amgen
- Arena Pharmaceuticals
- AstraZeneca
- BioGaia
- Bristol Myers Squibb
- Bukwang Pharmaceutica
- Chr. Hansen
- Cipla
- CoLucid
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DSM
- Eisai
- Eli Lilly
- EMS
- Euradite
- Friggs
- Genomma Lab Internacional
- Glanbia
- Herbalife
- Himalaya Drug Company
- Hypermarcas
- Immune Pharmaceuticals
- Innovative Med Concepts
- Mcneil consumer healthcare
- Mead Johnson
- Merck
- Mitsubishi Tanabe Pharma
- NeurAxon
- Omega Pharma
- OptiNose
- Pain Therapeutics
- Procter & Gamble
- Reckitt Benckiser
- SAVA
- Sigma Pharmaceuticals
- Sun Pharma
- Taisho Pharmaceuticals
- Takeda Pharmaceuticals
- Teva Pharmaceuticals
- UCB
- Unifarma Global Consumer healthcare
- Valeant Pharmaceuticals
- Vida Laboratories
Market driver
- Switching of medications from prescription to OTC
- For a full, detailed list, view our report
Market challenge
- Counterfeit drugs
- For a full, detailed list, view our report
Market trend
- Accelerated use of online resources
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key Market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Download the full report: https://www.reportbuyer.com/product/4068959/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article